Literature DB >> 23337560

Integrative medicine outcomes: what should we measure?

Jennifer Hunter1, Katherine Corcoran, Stephen Leeder, Kerryn Phelps.   

Abstract

The outcomes of Integrative medicine (IM) that combine biomedicine with traditional, complementary and alternative medicine (TCAM) are broad, reflecting the integration. IM is concerned with acute and chronic diseases, holistic approaches, and health promotion and wellness. Before commencing a research program in a primary care IM clinic, stakeholders were interviewed about IM outcomes. Everyone thought Physical Health and Mental Health were important. Those with a more holistic view of health thought a broader range of topics should be measured. Less important topics were lifestyle; health-related aspects of life satisfaction and quality of life; and healthcare evaluation. However, no one thought these should be excluded. Spirituality was the most contentious. Some commended its inclusion. For others, once religiousness and God were removed, the remaining elements should be relocated to the domains of mental health and life satisfaction. The results highlight the importance of consulting stakeholders before measuring outcomes.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23337560     DOI: 10.1016/j.ctcp.2012.10.002

Source DB:  PubMed          Journal:  Complement Ther Clin Pract        ISSN: 1744-3881            Impact factor:   2.446


  5 in total

1.  Guidance for establishing an integrative oncology service in the Australian healthcare setting-a discussion paper.

Authors:  Suzanne J Grant; Jennifer Hunter; Alan Bensoussan; Geoff P Delaney
Journal:  Support Care Cancer       Date:  2017-09-01       Impact factor: 3.603

2.  Integrative health care - What are the relevant health outcomes from a practice perspective? A survey.

Authors:  Ania Kania-Richmond; Amy Metcalfe
Journal:  BMC Complement Altern Med       Date:  2017-12-22       Impact factor: 3.659

Review 3.  An interpretive review of consensus statements on clinical guideline development and their application in the field of traditional and complementary medicine.

Authors:  Jennifer Hunter; Matthew Leach; Lesley Braun; Alan Bensoussan
Journal:  BMC Complement Altern Med       Date:  2017-02-17       Impact factor: 3.659

4.  Stop, Listen, and Learn: Using Mixed Methods to Add Value to Clinical Trials.

Authors:  Jennifer Hunter; Mike Armour
Journal:  J Evid Based Integr Med       Date:  2019 Jan-Dec

5.  Australian integrative oncology services: a mixed-method study exploring the views of cancer survivors.

Authors:  Jennifer Hunter; Jane Ussher; Chloe Parton; Andrew Kellett; Caroline Smith; Geoff Delaney; Eleanor Oyston
Journal:  BMC Complement Altern Med       Date:  2018-05-09       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.